INTUITIVE SURGICAL INC (ISRG)
Data as of , from SEC Form 4 filings.
S&P 500NASDAQ-100XNASORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIESNet insider selling (90d)Watch ISRG
See up to 3 months of ISRG. The 7-day demo opens the 1M and 3M ranges and puts ISRG on your watchlist.
Start 7-day demoLatest ISRG insider trades
About INTUITIVE SURGICAL INC (ISRG)
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.
- SUNNYVALE, CA
- 17,021
- 2000
- XNAS
ISRG Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 20 | 12,603 | $4.98M |
| Option exercise | 8 | 11,682 | |
| Tax withholding / forfeiture | 2 | 2,358 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ISRG insider transactions (Form 4)
75139 Form 4 filings on record, the earliest from Oct 10, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Patricia L. Wadors - Officer | Option exercise | Common Stock | 2,140 | $0.00 | - | |
| Patricia L. Wadors - Officer | Tax withholding / forfeiture | Common Stock | 1,062 | $423.96 | $450K | |
| Patricia L. Wadors - Officer | Option exercise | Restricted Stock Units - 10-10-2024 | 2,140 | $0.00 | - | |
| Gary Loeb - Officer | Option exercise | Common Stock | 2,612 | $0.00 | - | |
| Gary Loeb - Officer | Tax withholding / forfeiture | Common Stock | 1,296 | $423.96 | $549K | |
| Gary Loeb - Officer | Option exercise | Restricted Stock Units | 2,612 | $0.00 | - | |
| Fredrik Widman - Officer | Option exercise | Common Stock | 546 | $79.64 | $43K | |
| Fredrik Widman - Officer | Open-market sale | Common Stock | 546 | $374.44 | $204K | |
| Fredrik Widman - Officer | Option exercise | Common Stock | 543 | $109.49 | $59K | |
| Fredrik Widman - Officer | Open-market sale | Common Stock | 543 | $374.44 | $203K | |
| Fredrik Widman - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 546 | $0.00 | - | |
| Fredrik Widman - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 543 | $0.00 | - | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 23 | $347.66 | $8K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 25 | $365.79 | $9K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 46 | $361.23 | $17K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 23 | $350.20 | $8K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 77 | $396.37 | $31K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 77 | $375.57 | $29K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 77 | $390.67 | $30K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 77 | $394.00 | $30K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 77 | $394.26 | $30K | |
 Gary S. Guthart - Director | Open-market sale | Common Stock | 10,000 | $400.00 | $4.00M | |
 Amy L. Ladd - Director | Open-market sale | Common Stock | 400 | $379.00 | $152K | |
| Amy L. Ladd - Director | Open-market sale | Common Stock | 72 | $393.10 | $28K | |
| Gary Loeb - Officer | Open-market sale | Common Stock | 400 | $379.00 | $152K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 28 | $351.00 | $10K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 28 | $346.83 | $10K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 28 | $344.00 | $10K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 28 | $365.58 | $10K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 28 | $360.21 | $10K | |
 David J. Rosa - Officer | Option exercise | Common Stock | 1,910 | $0.00 | - | |
| David J. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 947 | $411.55 | $390K | |
| David J. Rosa - Officer | Option exercise | Restricted Stock Units | 1,910 | $0.00 | - | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 23 | $412.16 | $9K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 25 | $414.13 | $10K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 23 | $420.12 | $10K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 23 | $421.13 | $10K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 23 | $424.14 | $10K | |
| Gary Loeb - Officer | Open-market sale | Common Stock | 400 | $424.14 | $170K | |
| David J. Rosa - Officer | Option exercise | Restricted Stock Units - 6-12-23 | 1,358 | $0.00 | - | |
| David J. Rosa - Officer | Option exercise | Common Stock | 1,358 | $0.00 | - | |
| David J. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 674 | $426.61 | $288K | |
| Iman Jeddi - Officer | Option exercise | Common Stock | 5,625 | $77.00 | $433K | |
| Iman Jeddi - Officer | Open-market sale | Common Stock | 5,625 | $420.55 | $2.37M | |
| Iman Jeddi - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 5,625 | $0.00 | - | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 18 | $446.04 | $8K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 18 | $439.80 | $8K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 18 | $422.47 | $8K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 18 | $440.70 | $8K | |
| Mark Brosius - Officer | Open-market sale | Common Stock | 18 | $440.38 | $8K | |
| Gary Loeb - Officer | Open-market sale | Common Stock | 400 | $446.95 | $179K | |
| Gary S. Guthart - Director | Grant or award | Restricted Stock Units - 4-30-2026 | 554 | $0.00 | - | |
| Monica P. Reed - Director | Option exercise | Common Stock | 531 | $0.00 | - | |
| Monica P. Reed - Director | Option exercise | Restricted Stock Units | 531 | $0.00 | - | |
| Monica P. Reed - Director | Grant or award | Restricted Stock Units - 4-30-2026 | 554 | $0.00 | - | |
| Jami K. Nachtsheim - Director | Option exercise | Common Stock | 531 | $0.00 | - | |
| Jami K. Nachtsheim - Director | Option exercise | Restricted Stock Units | 531 | $0.00 | - | |
| Jami K. Nachtsheim - Director | Grant or award | Restricted Stock Units - 4-30-2026 | 554 | $0.00 | - | |
| Keith R. Leonard - Director | Option exercise | Common Stock | 531 | $0.00 | - | |
| Keith R. Leonard - Director | Option exercise | Restricted Stock Units | 531 | $0.00 | - | |
| Keith R. Leonard - Director | Grant or award | Restricted Stock Units - 4-30-2026 | 554 | $0.00 | - | |
| Amy L. Ladd - Director | Option exercise | Common Stock | 531 | $0.00 | - | |
| Amy L. Ladd - Director | Option exercise | Restricted Stock Units | 531 | $0.00 | - | |
| Amy L. Ladd - Director | Grant or award | Restricted Stock Units - 4-30-2026 | 554 | $0.00 | - | |
 Sreelakshmi Kolli - Director | Option exercise | Common Stock | 531 | $0.00 | - | |
| Sreelakshmi Kolli - Director | Option exercise | Restricted Stock Units | 531 | $0.00 | - | |
| Sreelakshmi Kolli - Director | Grant or award | Restricted Stock Units - 4-30-2026 | 554 | $0.00 | - | |
| Amal M. Johnson - Director | Option exercise | Common Stock | 531 | $0.00 | - | |
| Amal M. Johnson - Director | Option exercise | Restricted Stock Units | 531 | $0.00 | - | |
 Lewis Chew - Director | Option exercise | Common Stock | 531 | $0.00 | - | |
| Lewis Chew - Director | Option exercise | Restricted Stock Units | 531 | $0.00 | - | |
| Lewis Chew - Director | Grant or award | Restricted Stock Units - 4-30-2026 | 554 | $0.00 | - | |
| Joseph C. Beery - Director | Option exercise | Common Stock | 531 | $0.00 | - | |
| Joseph C. Beery - Director | Option exercise | Restricted Stock Units | 531 | $0.00 | - | |
| Joseph C. Beery - Director | Grant or award | Restricted Stock Units - 4-30-2026 | 554 | $0.00 | - |
Item 5.03, 9.01
Item 2.02, 9.01
Item 5.02, 9.01
Item 5.02, 5.07, 7.01
Recent ISRG Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| FREDRIK WIDMAN | Officer | 2,178 | $823K | View on EDGAR | |
| MARK BROSIUS | Officer | 694 | $254K |
Stock trades in ISRG disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
ISRG insider trading FAQ
What is the latest insider trade for ISRG?
INTUITIVE SURGICAL INC (ISRG) had 12 insider filings in the last 90 days, with the most recent on 2026-10-13. The full record for ISRG runs to 139 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ISRG stock?
No insider purchases of ISRG were filed in the last 90 days.
How many insiders are selling ISRG stock?
20 insider sales of ISRG were filed in the last 90 days, totaling $4.98M.
Where can I see ISRG SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ISRG Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Patricia L. Wadors view on EDGAR
- - Gary Loeb view on EDGAR
- - Fredrik Widman view on EDGAR
- - Mark Brosius view on EDGAR
- - Mark Brosius view on EDGAR
- - Mark Brosius view on EDGAR
- - Mark Brosius view on EDGAR
- - Gary S. Guthart view on EDGAR
- - Amy L. Ladd view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ISRG's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ISRG with a 7-day demo
- ISRG on your watchlist
- Every ISRG Form 4 filing on record
- Up to 3 months of ISRG price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
